Too Much Tamiflu! Medicaid Expansion and Anti-influenza Medications


Subscribe on iTunes

This week: Oregon Medicaid Expansion and a systematic review of anti-influenza medications.

Janice and Amol want you to:

1. Understand the effect of health care coverage expansion on health care utilization.

2. Understand the utility of randomized control trials in the formulation of causal inferences.

3. Recognize that anti-influenza antiviral medications appear to cause only a minor reduction in the duration of symptoms

4. Understand how access to clinical study reports might enhance transparency in clinical trials and improve health policy decisions

Continuing Medical Education

Internists can receive 0.5 hours of Continuing Medical Education credit for each podcast they listen to through the Canadian Society of Internal Medicine (MOC Category 1) and the American Medical Association (PRA Category 1). To receive CME credit for listening to this podcast, please click here to fill out our Evaluation and Impact Assessment Form.

The papers

Sarah L. Taubman et al. Medicaid Increases Emergency-Department Use: Evidence from Oregon’s Health Insurance Experiment. Science. 17 January 2014: Vol. 343 no. 6168 pp. 263-26. (PubMed).

Tom Jefferson et al. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ 2014;348:g2545.

Good stuff

Janice – Urban HEART @Toronto. Toronto Community Health Profiles. 

Amol (thanks to Andreas Laupacis for the tip) –  Sunshine List 2014: Ontario’s list drives salaries up, not down. Kazi Stastna. CBC News. April 1, 2014.

 

Leave a Comment

Enter the debate: reply to an existing comment
2 comments

  1. Jeremy Petch

    Very interesting episode. I think the medicaid expansion findings are indeed interesting – they’re very much in line with the experiences of my colleagues in family medicine who have taken patients from Ontario’s Health Care Connect program – often these patients haven’t had primary care in decades, so they arrive at their new family doctor’s office with multiple medical issues, often involving multiple chronic conditions. As a result, my colleagues frequently need to see these patients weekly, and their medical complexity means that it can take years before meaningful improvements in measurable outcomes can be obtained. They also note that since these patients are often of lower socioeconomic status, the social determinants of health continue to exert their influence, further impeding improvement in measurable health status.

    • Janice Kwan

      Thanks for your thoughtful comments, Jeremy. It will be interesting to follow this cohort over time to see if, and if so, how their health outcomes change over time. The jury appears to be out still on this fascinating question of substantial policy gravitas.

Submit a comment